[Federal Register Volume 62, Number 76 (Monday, April 21, 1997)]
[Notices]
[Page 19346]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-10189]



[[Page 19346]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings: National Advisory Allergy and Infectious Diseases Council; 
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology 
Subcommittee; Microbiology and Infectious Diseases Subcommittee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Allergy and Infectious Diseases Council, 
National Institute of Allergy and Infectious Diseases, and its 
subcommittees on May 19-20, 1997. Meetings of the Council, NAAIDC 
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious 
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be held at the National Institutes of Health, 
Bethesda, Maryland.
    The meeting of the full Council will be open to the public on May 
19 in Building 31C, Conference Room 6, from approximately 1 p.m. until 
3:30 p.m. for opening remarks of the Institute Director, discussion of 
procedural matters, Council business, and a report from the Institute 
Director which will include a discussion of budgetary matters. The 
primary program will include an update on activities of the NIAID 
Managed Care Working Group, and NIAID's intramural efforts in clinical 
research through tele-medicine.
    On May 20 the meetings of the NAAIDC Allergy and Immunology 
Subcommittee and NAAIDC Microbiology and Infectious Diseases 
Subcommittee will be open to the public from 8:30 a.m. until 
adjournment. The subcommittee will meet in Building 31C, conference 
rooms 8 and 6 respectively.
    The meeting of the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be open to the public from 8:30 a.m. until 
adjournment, on May 20. The subcommittee will meet in the Natcher 
Building, Conference Room LLD.
    In accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the 
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee, 
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology 
and Infectious Diseases Subcommittee will be closed to the public for 
approximately four hours for review, evaluation, and discussion of 
individual grant applications. It is anticipated that this will occur 
from 8:30 a.m. until 1 p.m. on May 19, in conference rooms 7, 8 and 6 
respectively. The meeting of the full Council will be closed from 3:30 
p.m. until recess on May 19 for the review, discussion, and evaluation 
of individual grant applications. These applications and the 
discussions could reveal confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the applications, disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.
    Ms. Claudia Goad, Committee Management Officer, National Institute 
of Allergy and Infectious Diseases, Solar Building, Room 3C26, National 
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will 
provide a summary of the meeting and a roster of committee members upon 
request. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should contact Ms. Goad in advance of the meeting.
    Dr. Lawrence Deyton, Acting Director, Division of Extramural 
Activities, NIAID, NIH, Solar Building, Room 3C20, 6003 Executive 
Boulevard, Rockville, Maryland 20892, telephone 301-496-7291, will 
provide substantive program information.

(Catalog of Federal Domestic Assistance Program Nos. 93.855 
Immunology, Allergic and Immunologic Diseases Research, 93.856, 
Microbiology and Infectious Disease Research, National Institutes of 
Health)

    Dated: April 14, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-10189 Filed 4-18-97; 8:45 am]
BILLING CODE 4140-01-M